Salona Global Medical Device Corporafion announced the debut of the Biodex SpaceTek Knee Device: A revolutionary, portable medical device for treating patients with knee replacements and knee injuries. The Company's intention is to submit an application for approval of the SpaceTek Knee Device with the U.S. Food and Drug Administration (the "FDA") in early 2024. The SpaceTek Knee Device is to be offered exclusively by Biodex Medical Systems Inc. (Biodex), and its price point is meant to democratize the Biodex institutional grade technology and intellectual property to physical therapy chiropractic centers in the United States.

Because of its compact size and price point, this product is designed to expand the current market for Biodex products. The SpaceTek Knee Device is portable, affordable and can be used in several locations depending on demand within a small clinic with the entire dynamometer and electronics packaged in a case weighing less than 70lbs. The SpaceTek Knee Device was co-developed in collaboration with the National Aeronautics and Space Administration (NASA) for use in outer space based on market leading technology available on the Biodex S4 (S4) isokinetic machine with dynamometers.

As the flagship product for Biodex, the S4 was created to treat knees, shoulders and other joints. However, because of its complexity and size, it has a large price tag and requires a trained expert to operate, historically limiting Biodex sales primarily to hospitals, universities, research centers, and sports teams. The company has built four prototypes which are expected to be available to the public in 2024 and are being used by Japanese, European and American distributors to finalize marketing and sales plans for 2024.